4.7 Article

Responsiveness and thresholds for clinically meaningful changes in worst pain numerical rating scale for dysmenorrhea and nonmenstrual pelvic pain in women with moderate to severe endometriosis

期刊

FERTILITY AND STERILITY
卷 115, 期 2, 页码 423-430

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2020.07.013

关键词

Endometriosis; pain; numerical rating scale; dysmenorrhea; nonmenstrual pelvic pain

资金

  1. AbbVie

向作者/读者索取更多资源

The study demonstrated the utility and responsiveness of separate numerical rating scales for assessing worst pain in women with moderate to severe endometriosis-associated pain, and identified initial thresholds for clinically meaningful change.
Objective: To evaluate the utility, responsiveness, and thresholds for clinically meaningful change of a numerical rating scale for worst pain associated with dysmenorrhea (NRS-DYS) and nonmenstrual pelvic pain (NRS-NMPP) in women with moderate to severe endometriosis-associated pain. Design: Analysis of data from two phase III randomized clinical trials (EM-I [NCT01620528] and EM-II [NCT01931670]). Setting: Not applicable. Patient(s): Premenopausal women ages 18-49 years with moderate to severe endometriosis-associated pain. Intervention(s): Participants in both trials were randomized 3:2:2 to receive placebo, elagolix 150 mg once daily, or elagolix 200 mg twice daily for 6 months. Main Outcome Measure(s): NRS-DYS and NRS-NMPP. Result(s): EM-I enrolled 871 women and EM-II enrolled 815 women. For patients with a global impression of improvement at month 3, the least-squares mean change between baseline and month 3 was -3.6 (EM-I and EM-II) for NRS-DYS and -1.9 (EM-I) and -2.0 (EMII) for NRS-NMPP. Standard errors of measurement were 2.99 (EM-I) and 2.86 (EM-II) for NRS-DYS and 1.74 (EM-I) and 1.71 (EM-II) for NRS-NMPP. Baseline half standard deviations were 0.78 (EM-I) and 0.85 (EM-II) for NRS-DYS and 0.92 (EM-I) and 0.96 (EM-II) for NRSNMPP. Conclusion(s): This study demonstrated the utility and responsiveness of separate numerical rating scales to assess worst pain for dysmenorrhea and NMPP in women with moderate to severe endometriosis-associated pain and identified initial thresholds for clinically meaningful change. ((C) 2020 by American Society for Reproductive Medicine.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据